OTC · CIMVF
Pideka Group Inc.
$0.01$0.00 (0.0%)
Pideka Group Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
Loading market information…
OTC · ACNNF · USD
Stock price, earnings
Quote as of Sep 9, 2024, 07:54 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow AusCann Group Holdings Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
AusCann Group Holdings Ltd currently has no significant operational activities. Historically, the company was dedicated to the research, development, and commercialization of diverse therapeutic products originating from cannabinoids. Its corporate headquarters are located in West Perth, Australia.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:29 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$0.01$0.00 (0.0%)
Pideka Group Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.04-$0.00 (-2.67%)
CBD Global Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 65.37% below the high.
$0.00-$0.00 (-85.71%)
RCMW Group, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Kallo Inc.: Healthcare · Medical - Healthcare Information Services.
$0.01+$0.01 (+166.67%)
Silo Wellness Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.50+$0.17 (+51.52%)
Irwin Naturals Inc.’s quoted price sits in the lower half of its reported 52-week range, 53.27% below the high.
$0.08-$0.09 (-51.52%)
Parnell Pharmaceuticals Holdings Ltd’s quoted price sits in the lower half of its reported 52-week range, 77.14% below the high.
$0.02+$0.00 (+16.18%)
Can B Corp.’s quoted price sits in the lower half of its reported 52-week range, 89.55% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
